Johnson & Johnson Expected to Post a Q1 Earnings Decline
With the talc legal issue settled and strong pharmaceutical sales, Johnson & Johnson is expected to see brighter days ahead after a first-quarter dip.
Trending
Symbol | Last Price | Change | % Change |
---|---|---|---|